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Summary
Background: In sub-Saharan Africa, HIV has increased the spectrum of central nervous system
(CNS) infections. The etiological diagnosis is often difficult. Mortality from CNS infections is
higher in sub-Saharan Africa compared to Western countries. This study examines the medical
management of CNS infections in Uganda. We also propose a clinical algorithm to manage CNS
infections in an effective, systematic, and resource-efficient manner.
Methods: We prospectively followed 100 consecutive adult patients who were admitted to
Mulago Hospital with a suspected diagnosis of a CNS infection without any active participation
in their management. From the clinical and outcome data, we created an algorithm to manage
CNS infections, which was appropriate for this resource-limited, high HIV prevalence setting.
Results: Only 32 patients had a laboratory confirmed diagnosis and 23 of these were diagnosed
with cryptococcal meningitis. Overall mortality was 39%, and mortality trended upward when the
diagnosis was delayed past 3 days. The initial diagnoses were made clinically without significant
laboratory data in 92 of the 100 patients. Because HIV positive patients have a unique spectrum of
CNS infections, we created an algorithm that identified HIV-positive patients and diagnosed those
with cryptococcal meningitis. After cryptococcal infection was ruled out, previously published
algorithms were used to assist in the early diagnosis and treatment of bacterial meningitis,* Corresponding author. Tel.: +1 801 261 9651; fax: +1 801 261 9656.
E-mail address: jtrachtenberg99@hotmail.com (J.D. Trachtenberg).
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tuberculous meningitis, and other common central nervous system infections. In retrospective
comparison with current management, the CNS algorithm reduced overall time to diagnosis and
initiate treatment of cryptococcal meningitis from 3.5 days to less than 1 day.
Conclusions: CNS infections are complex and difficult to diagnose and treat in Uganda, and are
associated with high in-hospital mortality. A clinical algorithmmay significantly decrease the time to
diagnose and treat CNS infections in a resource-limited setting.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
In sub-Saharan Africa, central nervous system (CNS) infec-
tions, such as bacterial meningitis (BM), tuberculous menin-
gitis (TbM), aseptic meningitis (AS), and primarily
HIV-specific CNS infections, such as cryptococcal meningitis
(CM) and toxoplasma encephalitis (TE), are associatedwith a
high mortality. Adult in-hospital mortality in sub-Saharan
Africa has been measured at 17—67% for BM,1—5 40—69% for
TbM,1,4—6 39—64% for CM,4,5,7 and 35% for AS.5 Incidence
rates for BM are up to 10-fold higher than in the USA or
Europe,8 and as the African AIDS epidemic accelerates, the
incidence of CNS infections will presumably increase
further.9 The poor outcomes of CNS infections in sub-Saharan
Africa have not been well studied. A tangible understanding
of the current medical management of patients with CNS
infections in this setting may lead to systematic interven-
tions that could potentially improve survival.
Mulago Hospital is a 1500-bed, public, teaching hospital,
in Kampala, Uganda where an average of 40—60 patients are
admitted daily to the general medicine wards. Approximately
70% of these patients are HIV-positive. An average of two to
three patients are admitted with a presumed CNS infection
daily. A recent study in this hospital documented a 42% in-
hospital mortality rate for CM.10 Mortality rates for other CNS
infections were also perceived to be high. Concerned by high
mortality rates, the Department of Medicine at Mulago Hos-
pital investigated themanagement of CNS infections with the
intent to develop an effective, resource-efficient algorithm
to care for these patients.
This study documents the clinical presentations, spectrum
of diseases, and outcomes in 100 consecutive adults admitted
to Mulago Hospital with presumed CNS infections. The study
explores the process by which physicians arrive at an initial
diagnosis, decide on therapy, and order diagnostic proce-
dures. It also identifies potential strategies to decrease in-
hospital mortality through the development of a diagnostic
and treatment algorithm to guide patient care in this HIV-
prevalent, resource-limited setting. The algorithm was then
compared to the current medical practice for the treatment
of proven CM infection to measure its potential impact.
Methods
Institutional review boards at Makerere University School of
Medicine and University of Utah School of Medicine approved
this study.
During six weeks in September, October and November
2002, the investigators prospectively observed the presenta-
tion, workup and treatment, and outcomes of 100 consecu-
tive adult patients admitted to the general medicine wards atMulago Hospital with the presumed diagnosis of a CNS infec-
tion. These investigators did not participate in patient care.
Investigators reviewed the daily admission log for adult
patients with presumed CNS infections, including CM, BM,
TbM, TE, AS, unexplained or new-onset psychosis, and cere-
bral malaria. Participants who were at least 18 years old and
who had been admitted to the medical ward with a presumed
CNS infection were identified, and consent was obtained
from the patient or a family member.
Each patientwas entered into the studywithin 24 hours of
admission and was visited by the investigator every 3 days
until discharge or in-hospital death. Study investigators
reviewed medical progress notes and laboratory results.
The investigators interviewed and examined the patients
during each visit, and recorded the historical and physical
information, daily diagnoses, orders, procedures, labora-
tory values, and progress of each patient on a standardized
form.
From the observations and data, the investigators identi-
fied strategies to improve patient care and developed the
algorithm for the management of suspected CNS infections.
The time to diagnose and initiate treatment for the 23
patients with a laboratory-proven diagnosis of CM was retro-
spectively compared between the current conditions and the
algorithm.
Statistical analysis
The Cox proportional hazard model was used to elicit specific
risk factors associated with in-hospital mortality.
Results
Clinical presentation and evaluation of medical
care
Demographics on presentation
Historical and clinical data are presented in Table 1. Almost
one-third of the patients were known to be HIV-positive, and
roughly two-thirds did not know their HIV status. One quarter
of patients had been treated for pulmonary tuberculosis. The
duration of the presenting illness ranged from 1 to 90 days
(mean 13.0 days). Over half the patients had sought medical
care before presenting at the hospital. At least 33 patients
had been prescribed oral antibiotics, and 26 antimalarials,
within 48 hours of admission.
Initial evaluation
On admission clinicians presumed that 46 patients had CM, 16
had BM, 14 had TE, 13 had malaria, four had viral menin-
goencephalitis, four had TbM, and three had acute psychosis.
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Table 1 Demographics of 100 consecutive patients with a
presumed central nervous system infection
Gender distribution 51 male, 49 female
Age (years) Mean 33.3 (range 18—53)
(male 31.9, female 34.7)
HIV status 3 known negative
31 known positive
66 unknown status
On HAART therapy 4
Past history of tuberculosis 25
Duration of illness (days) Mean 13.0 (range 1—90)
c/o Fever 71
c/o Confusion 66
c/o Neck pain 48 (2 unknown)
c/o Headache 74
c/o Seizure 29
c/o Focal deficit 14 (2 unknown)
Antibiotic use within
48 hours of admission
33 (12 unknown)
Antimalarials use within
48 hours of admission
26 (14 unknown)
Stiff neck on exam 33
Focal deficit on exam 23
Skin rash on exam 21
Thrush on exam 34
HAART: highly active antiretroviral treatment; c/o: complaint of.Because CM was by far the most common presumed
diagnosis, clinical signs and symptoms associated with a
presumed admission diagnosis of CM were compared to those
with other presumed admission diagnoses (Table 2). PresenceTable 2 Demographic and clinical risk factors associated with the
vs. other presumed diagnoses combined (Chi-square or Fisher’s ex
Risk factor CM (n = 46)
Male 20
Female 26
Age <33 years 18
History of tuberculosis 17
Duration <14 days 33
c/o Fever 30
c/o Confusion 29
c/o Neck pain 27
c/o Headache 44
c/o Seizure 5
c/o Focal deficit 5
Antibiotic use within 48 hours of admission 17
Antimalarial use within 48 hours of admission 9
GCS <14 19
Karnofsky <80 20
Stiff neck on exam 18
Focal deficit on exam 4
Skin rash on exam 13
Thrush on exam 20
Admitting physician assuming the patient is
immunosuppressed
45
c/o: complaint of; GCS: Glasgow Coma Scale.of a headache, clinical immunosuppression, the lack of a
seizure, and the lack of a focal neurological deficit on
admission were presenting signs and symptoms which were
consistently found in the 46 patients who were given the
clinical diagnosis of cryptococcal meningitis (44, 45, 41, 42 of
these patients, respectively) and were present significantly
more often than in those patients given alternative admitting
diagnoses (Chi-square).
While analysis was not done on the presenting signs and
symptoms associated with other diagnoses, all patients with
acute onset of stiff neck and fever were given the diagnosis of
BM, and all six who were given a diagnosis of TE had evidence
of focal neurological defects.
Laboratory work-up
Few of the initial diagnoses were actually confirmed and
there was considerable variability in the diagnostic work-up,
even among patients with the same admission diagnosis
(Table 3). The inconsistent approach to diagnosis was the
result of physician variability, lack of a defined, systematic
approach to diagnose CNS infections, patients’ inabilities and
unwillingness to pay for tests, patients’ refusal to undergo a
lumbar puncture (LP), and the lack of readily available basic
laboratory tests.
An evaluation of the use of LPs was particularly revealing.
Physicians ordered an LP in 88 patients on the first day of
admission, but only 57 received an LP, and of these, 54 results
were reported. There was a significant delay in performing an
LP. Physicians performed an LP a mean of 2.5 days after
admission. Reasons for failure to perform LPs in a timely
manner included lack of LP needles and bottles, limited
working hours of the laboratory, patient response to empiric
treatment, patient mortality before the LP was performed,
and patient refusal to receive an LP. Even when the LP waspresumed admission diagnosis of cryptococcal meningitis (CM)
act test)
Other (n = 54) Relative risk (95% CI) p Value
31 1.4 (1.9—2.0) 0.16
23 1.4 (1.9—2.1) 0.16
36 0.6 (0.4—0.9) 0.01
8 1.6 (1.1—2.3) 0.03
45 0.7 (0.5—1.1) 0.16
41 0.8 (0.5—1.2) 0.24
37 0.9 (0.6—1.4) 0.56
21 1.5 (1.0—2.3) 0.07
30 4.2 (1.1—15.6) 0.003
24 0.3 (0.1—0.7) <0.001
9 0.8 (0.4—1.6) 0.41
16 1.2 (0.8—1.9) 0.47
17 0.7 (0.4—1.2) 0.15
33 0.6 (0.4—1.0) 0.05
28 0.8 (0.5—1.3) 0.40
15 1.3 (0.9—2.0) 0.23
19 0.3 (0.1—0.8) <0.001
8 1.5 (1.0—2.3) 0.10
14 1.3 (0.9—1.9) 0.22
32 13.4 (2.0—92.0) <0.001
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Table 3 Admission diagnosis, work-up, and mortality of 100 consecutive adult patients admitted to Mulago Hospital with a
presumed central nervous system infection
Diagnosis
on
admission
Frequency Method by which
the ADx was
derived (%)
Received
LP (%)
Days to
receive LP
mean (range)
Received
sCrAg (%)
Received
CT (%)
Received
CXR (%)
Received
B/S (%)
Mortality
(%)
CM 46 H+P: 40 (87) 37 (80) 2.4 (1—6) 7 (15) 3 (7) 18 (39) 6 (13) 18 (39)
CSF: 4 (9)
SCrAg: 2 (4)
BM 16 H+P: 15 (93) 9 (56) 2.6 (1—7) 4 (25) 2 (13) 4 (25) 5 (31) 10 (63)
CSF: 1 (7)
TE 14 H+P: 14 (100) 4 (29) 2.5 (1—5) 3 (21) 5 (36) 7 (50) 2 (14) 7 (50)
Malaria 13 H+P: 13 (100) 3 (23) 2.7 (2—3) 0 0 0 5 (38) 1 (7)
VME 4 H+P: 4 (100) 1 (25) 2.0 1 (25) 0 0 2 (50) 2 (50)
TbM 4 H+P: 3 (75) 2 (50) 2.5 (2—3) 0 0 2 (50) 1 (25) 1 (25)
CXR: 1 (25)
Psych 3 H+P: 3 (100) 1 (33) 5.0 0 0 1 (33) 0 0
Total 100 H+P: 92 57 2.5 (1—7) 15 10 32 21 39
CSF: 5
sCrAg: 2
CXR: 1
ADx: presumed admission diagnosis; Received: received during the hospital admission; LP: lumbar puncture; sCrAg: serum cryptococcal
antigen; CT: computerized tomography scan of the head; CXR: chest X-ray; B/S: blood slide for malaria parasites; CM: cryptococcal
meningitis; BM: bacterial meningitis; TE: toxoplasma encephalitis; Malaria: cerebral malaria; VME: viral meningoencephalitis; TbM:
tuberculous meningitis; Psych: acute psychosis; H+P: history and physical; CSF: cerebrospinal fluid analysis.finally done, most cerebrospinal fluid (CSF) analyses were not
complete. Forty-two (78%) reported total leukocyte count,
four (7%) reported leukocyte count differential, 45 (83%)
reported protein, 10 (19%) reported glucose, 47 (87%)
reported India ink, 47 (87%) reported Gram stain, and 24
(44%) reported culture.
Final diagnoses
Final diagnoses were eventually confirmed in only 32
patients: 23 with CM (19 by India ink and culture, four only
by serum cryptococcal antigen (sCrAg)), two with BM by Gram
stain only, and one with malaria. Confirmed non-CNS infec-
tious causes, which mimicked CNS infections, were one
subarachnoid hemorrhage, one subdural hematoma, one
cerebral vascular accident, one delirium tremens, one filar-
iasis, and one broncho-pneumonia.
Of the 23 patients with a confirmed final diagnosis of CM,
20 had a presumed admission diagnosis of CM, two had a
diagnosis of TbM, and one had a diagnosis of BM. Of the two
patients with confirmed BM, one was diagnosed on admission
as viral meningitis and one as CM. The one patient with
proven cerebral malaria was thought to have malaria on
admission.
The average number of days to diagnose and initiate
treatment for the 23 patients with confirmed CM was 3.5
days.
Appropriateness of selection and timing of initial
treatment
Physicians administered empiric antibiotics on the first day of
admission, but prior to a diagnostic procedure in the majority
of patients. Fifty-four patients received intravenous penicillin
and chloramphenicol, 31 received intravenous antimalarials;17 of these patients received both regimens. All 16 patients
with a presumed diagnosis of BM received penicillin and
chloramphenicol within the first day of admission and prior
to a diagnostic LP.
Patients often received antimicrobials even if a diagnosis
of BM or cerebral malaria was not expected. For example, 24
of 46 patients with suspected CM received intravenous peni-
cillin and chloramphenicol, two received intravenous anti-
malarials, and three received both. It was hospital policy not
to administer either amphotericin B or fluconazole for CM,
until the diagnosis was definitively ‘proven’.
Microbiologically confirmed diagnoses were definitively
treated in a mean of 3.4 days after admission (range 1—10
days). For highly suspected diagnoses, targeted treatment
was initiated in a mean of 4.1 days (range 1—14 days). For
diagnoses that were not confirmed and not highly suggestive,
physicians started empiric antibiotics in a mean of 1.5 days
after admission (range 1—7 days).
Factors related to mortality
Overall, in-hospital mortality in this group of patients was
39%. In-hospital mortality of the 32 confirmed and 68 uncon-
firmed cases were 17 vs. 22, respectively ( p = 0.67). The
insignificant difference can be explained in that the majority
of confirmed cases were CM, which had a high mortality rate
of 48%.
Several factors were associated with in-hospital mortal-
ity (Table 4). Using days to receive a final diagnosis, the
patients were divided into quartiles. Quartile 1 included
patients who had received a final diagnosis by hospital day
1—3; those in quartile 2 had received a final diagnosis by
hospital day 4—5; those in quartile 3 had received a final
diagnosis by hospital day 6—11; and those in quartile 4 had
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Table 4 Risk factors for in-hospital mortality
Risk factor Hazard ratio SE z p > (z) 95% CI
Final diagnosis made by days 4—5 2.73 1.50 1.82 0.068 0.93—8.01
Final diagnosis made by days 6—11 0.99 0.48 0.01 0.996 0.39—2.54
Final diagnosis made by days 12—40 0.29 0.15 2.43 0.015 0.11—0.79
Admission Glasgow Coma Scale 0.87 0.04 3.07 0.002 0.80—0.95
Admission c/o neck pain 2.08 0.69 2.19 0.028 1.08—4.01
Received empiric antibiotics 3.18 1.73 2.13 0.033 1.10—9.21
Cox proportional hazard model of risk factors relating to in-hospital mortality; day 1—3 is referent.
SE: standard error; c/o: complaint of.received a final diagnosis by hospital day 12—40. Because the
final diagnosis ideally is obtained within the first three days
of hospital admission, we used quartile 1 as a reference to
determine the hazard ratio for in-hospital mortality related
to delay in diagnosis. By Cox proportional hazard model,
mortality increased and trended toward significance in
patients in quartile 2 (hazard ratio 2.73, p = 0.068, 95% CI
0.93—8.01). Those patients who were diagnosed after day 5
had decreased mortality, possibly representing more indo-
lent disease. Other risk factors associated with in-hospital
mortality were a low admission Glasgow Coma Scale (GCS)
score (<14 out of a maximal score of 15), presence of neck
pain on admission, and initial treatment on admission with
empiric penicillin and chloramphenicol. Patients who
received empiric penicillin and chloramphenicol tended to
be more ill.
Diagnostic and treatment algorithm
Upon review of the above data, we created an algorithm
unique to the HIV prevalent, resource-limited medical set-
ting (Figure 1). The algorithm first prioritizes the diagnosis of
HIV and CM. It then incorporates aspects of previously pub-
lished guidelines for BM and TbM, which would be reasonable
for a resource-limited setting.11—20 The goal is to reach a
targeted diagnosis and initiate effective treatment within
hours. Though this algorithm is designed specifically for a
resource-limited medical setting, the algorithm requires
basic laboratory procedures that are generally available.
These include rapid HIV testing, access to an LP tray with
the ability to do a manual cell count, glucose analysis, Gram
stain, and India ink, and a malaria smear. Additional helpful
labs include chest X-ray, serum cryptococcal antigen, and CSF
culture. The algorithm guides the clinician to when it is
appropriate to transfer to a referral hospital with more
sophisticated tests (i.e., CT scan) when possible.
Discussion
At Mulago Hospital, and perhaps in many hospitals in sub-
Saharan Africa, the prevalence of HIV expands the differen-
tial diagnosis of CNS infections. AIDS-related illnesses, and
especially cryptococcal meningitis, are common. Social,
manpower, and laboratory factors delay the LP and limit
the utility of CSF analysis because empiric therapy is usually
initiated prior to this diagnostic procedure. The CT scan,
which is included in all Western clinical algorithms, is not
available or affordable in most resource-limited settings.
Indeed, a recent evaluation of laboratory medicine in Africarevealed that this aspect of healthcare in general is a barrier
to quality patient care.21
As a result, physicians must treat clinical syndromes and
rely heavily on response to treatment to determine the
accuracy of their diagnosis. Clinical signs and symptoms of
several diagnoses overlap. Previously published algorithms
generally are microbe-specific and do not allow the differ-
entiation of one etiology from another. This algorithm treats
CNS infection, and its signs and symptoms, as a single syn-
drome, and guides the clinician to not only an etiological
diagnosis, but also a treatment plan.
In the population observed at Mulago Hospital, HIV pre-
valence is approximately 70%. Although CM, BM, TbM, and TE
in this patient population have a very high mortality, they are
treatable diseases if the diagnosis is made and treatment is
begun in a timely fashion.
The first critical step is to identify those patients who are
HIV positive. A recent study at Mulago Hospital reveals that
voluntary counseling and testing for HIV is well accepted.
Seventy percent of those patients who were offered testing
accepted it.22 Themain reason not to test was the inability to
pay. Voluntary counseling and testing not only assists the
clinician in making a diagnosis, but is also a key instrument
for HIV prevention.22 This should convince Ministries of
Health to offer testing freely and also make it an ‘opt out’
policy for all patients being admitted to a hospital in sub-
Saharan Africa. If testing is not available, clinical markers of
immunosuppression (wasting, thrush, Kaposi’s sarcoma, etc.)
are supportive evidence of AIDS.
Almost one half of the patients admitted for a CNS infec-
tion in this study had a presumed admission diagnosis of CM.
This diagnosis is relatively simple, inexpensive, and rapid to
make with India ink examination of the CSF or a positive
serum or CSF cryptococcal antigen (CrAg). The serum antigen
(sCrAg) has a sensitivity and specificity of 98% and 99%,
respectively.23,24 This test is underutilized and should be
employed, if not on all HIV-positive patients with suspected
meningitis, then at least in all patients with suspected CM
who refuse an LP or who have a negative CSF India ink exam.
In a cohort of patients with meningitis in Uganda, French
et al., demonstrated that the sCrAg predates clinical symp-
toms of meningitis by a median of 22 days.25 Increasing the
use of the sCrAg would substantially decrease empiric anti-
biotics and hasten the administration of anti-cryptococcal
agents.
In contrast, BM and TbM can be more difficult to diagnose.
Identification of acid-fast bacilli in CSF is insensitive, myco-
bacterial culture is clinically impractical for the treatment of
Tb, and few resource-limited settings have the capability to
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Figure 1 Diagnostic and treatment algorithm for central nervous system infections in resource-limited medical settings.perform PCR. Thus the diagnosis of TbM depends on the
patient’s clinical syndrome, predominance of lymphocytes
in the setting of a low CSF glucose, and lack of clinical
response to BM treatment. Thwaites et al., created an
effective and practical algorithm to distinguish BM from
TbM in Vietnam.20 While the Vietnam algorithm requires
validation in an area with a high prevalence of HIV, the
approach of repeating CSF analysis in every patient with a
low CSF glucose to monitor response to treatment, is reason-
able in any resource-limited setting.
Clinical algorithms improve patient outcomes in the
treatment of ischemic heart disease,26 stroke,27 and com-
munity-acquired pneumonia28 in Western countries. Most
published clinical pathways for diagnosis and treatment of
bacterial meningitis are not practical for a resource-limitedsetting, and do not address the high prevalence of HIV in
places like sub-Saharan Africa, as well as the lack of
resources to make a rapid and accurate diagnosis. This
algorithm is being evaluated at Mulago Hospital and smaller
regional medical centers in Uganda. As well, additional
studies may improve the algorithm. Surveying bacterial
isolates and antibiotic susceptibility will determine the
appropriateness of penicillin and chloramphenicol as ade-
quate empiric antimicrobials for presumed BM. Further
evidence of the risks of performing LPs in patients with
encephalopathy, new onset-seizure, or focal neurological
deficit without prior CT imaging in an HIV-prevalent popula-
tion will enable clinicians to be more definitive about
proceeding with this procedure in resource-limited areas.
The safety and utility of administering dexamethasone to
530 J.D. Trachtenberg et al.adults with presumed BM in an area with a high prevalence of
HIV should also be studied.
This study reveals that CNS infections are ominous diag-
noses at Mulago Hospital, and presumably reflects the experi-
ence at most medical centers in sub-Saharan Africa.
However, basic and inexpensive systemic improvements have
the potential to substantially improve the current medical
practice. An algorithm-driven standard of care and utiliza-
tion of resources may decrease in-hospital mortality. Evalua-
tion and possible implementation of this strategy should be
considered for resource-limited medical centers where HIV
prevalence is high and CNS infections are a major cause of
illness and death.
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